152 related articles for article (PubMed ID: 741533)
21. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract.
Hakala TR; Lange PH
Science; 1974 May; 184(4138):795-7. PubMed ID: 4856602
[TBL] [Abstract][Full Text] [Related]
22. MHC nonrestricted cytotoxic T cell clones with selective specificity from patients with transitional cell carcinoma (TCC) of the urinary bladder.
Hansson Y; Vargas-Cortes M; Paulie S; Perlmann P
Cancer Immunol Immunother; 1988; 27(3):205-12. PubMed ID: 3263206
[TBL] [Abstract][Full Text] [Related]
23. Lymphoid cells mediating tumor-specific cytotoxicity to carcinoma of the urinary bladder. Separation of the effector population using a surface marker.
O'Toole C; Stejskal V; Perlmann P; Karlsson M
J Exp Med; 1974 Mar; 139(3):457-66. PubMed ID: 4591169
[TBL] [Abstract][Full Text] [Related]
24. Cell-mediated cytotoxicity against human bladder cancer.
Bloom ET; Ossorio RC; Brosman SA
Int J Cancer; 1974 Sep; 14(3):326-34. PubMed ID: 4477556
[No Abstract] [Full Text] [Related]
25. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture.
Pape GR; Troye M; Perlmann P
J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130
[No Abstract] [Full Text] [Related]
26. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
27. Effects of bacillus Calmette-Guerin on cytotoxic activities of peripheral blood lymphocytes against human T24 lined and freshly isolated autologous urinary bladder transitional carcinoma cells in patients with urinary bladder cancer.
Mizutani Y; Nio Y; Fukumoto M; Yoshida O
Cancer; 1992 Jan; 69(2):537-45. PubMed ID: 1728384
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte response to transitional cell carcinoma: peripheral cytotoxicity and local tumor infiltration.
Jones LW; O'Toole C
J Urol; 1977 Dec; 118(6):974-7. PubMed ID: 926279
[TBL] [Abstract][Full Text] [Related]
29. Correlation of primary tumor bed lymphocytic infiltration and peripheral lymphocyte cytotoxicity in patients with transitional cell carcinoma.
Jones LW; O'Toole C
Natl Cancer Inst Monogr; 1978 Dec; (49):183-5. PubMed ID: 748770
[TBL] [Abstract][Full Text] [Related]
30. Lymphocyte-mediated cytotoxicity in patients with renal and transitional cell carcinoma receiving BCG.
Lange PH
Natl Cancer Inst Monogr; 1978 Dec; (49):343-5. PubMed ID: 748791
[TBL] [Abstract][Full Text] [Related]
31. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
Hermann GG; Zeuthen J; Claësson MH
Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte cytotoxicity against autologous bladder tumor cells in humans, investigated by use of a chromium-51 release assay.
Jacobsen F
Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):175-80. PubMed ID: 7315355
[TBL] [Abstract][Full Text] [Related]
33. Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.
Moltó LM; Carballido J; Jurincic C; Lapeña P; Manzano L; Salmerón I; Klippel KF; Alvarez-Mon M
Eur Urol; 1991; 19(1):74-8. PubMed ID: 2007423
[TBL] [Abstract][Full Text] [Related]
34. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma.
Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P
Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441
[TBL] [Abstract][Full Text] [Related]
35. Cellular and humoral in vitro cytotoxicity against autologous bladder tumor cells in humans. Differences in autologous cytotoxicity against non-invasive and invasive transitional-cell tumors of the urinary bladder.
Jacobsen F
Acta Pathol Microbiol Scand C; 1981 Aug; 89(4):235-9. PubMed ID: 7315359
[TBL] [Abstract][Full Text] [Related]
36. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
37. The specificity of the microcytotoxicity assay for cell-mediated immunity in human bladder cancer.
Vilien M; Wolf H
J Urol; 1978 Mar; 119(3):338-42. PubMed ID: 273706
[TBL] [Abstract][Full Text] [Related]
38. Peripheral blood lymphocyte response in patients with superficial transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guérin--a useful marker of response?
Schmidt AC; Bouic PJ; Heyns CF; De Kock ML
Br J Urol; 1993 Feb; 71(2):179-82. PubMed ID: 8461951
[TBL] [Abstract][Full Text] [Related]
39. Effect of BCG immunotherapy on cell-mediated cytotoxicity in bladder cancer patients following surgical treatment.
Antonaci S; Piccinno A; Lucivero G; Miglietta A; Piccininno A; Bonomo L
Tumori; 1981; 67(3):177-82. PubMed ID: 6974423
[No Abstract] [Full Text] [Related]
40. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells?
O'Toole C; Perlmann P; Wigzell H; Unsgaard B; Zetterlund CG
Lancet; 1973 May; 1(7812):1085-8. PubMed ID: 4123535
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
